RecruitingNot ApplicableNCT07124390

Electroacupuncture as a Treatment for Refractory Overactive Bladder

Electroacupuncture as a Treatment for Refractory Overactive Bladder: A Feasibility /Pilot Randomized Controlled Trial


Sponsor

Chelsea and Westminster NHS Foundation Trust

Enrollment

24 participants

Start Date

Aug 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a single-site feasibility randomised controlled trial evaluating the feasibility and acceptability of electroacupuncture (EA), and percutaneous tibial nerve stimulation (PTNS), in women with refractory overactive bladder (OAB) who have not achieved satisfactory improvement following standard pelvic health physiotherapy. The primary aim is to determine whether a larger definitive trial is feasible by assessing recruitment, consent, retention, treatment adherence, data completeness, intervention delivery, safety, and participant acceptability. Twenty-four participants will be randomly allocated to receive electroacupuncture or PTNS, over a 12-week treatment period. Outcome assessments will be completed at baseline, 6 weeks, 12 weeks, 6 months, and 12 months. The findings will inform the design of a future definitive randomised controlled trial and contribute to the evidence base for non-pharmacological treatment options for overactive bladder.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Name: Electroacupuncture (EA) Type: Device-based acupuncture therapy and a medical device called Neuromodulation therapy for people with nocturia, over active bladder, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEName: Electroacupuncture (EA) Type: Device-based acupuncture therapy

Description: Insertion of acupuncture needles at specific points with electrical stimulation (20 Hz) for 30 minutes per session.

DEVICENeuromodulation therapy

Type: Neuromodulation therapy Description: Insertion of a needle electrode near the medial malleolus with low-voltage electrical stimulation (20 Hz) applied for 30 minutes per session.


Locations(1)

Chelsea and Westminster hospital NHS foundation Trust

London, United Kingdom, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07124390


Related Trials